What is Pulse NeedleFree Systems?
Pulse NeedleFree Systems operates at the intersection of veterinary medicine and precision agriculture. The company specializes in the development and deployment of advanced needle-free injection systems, such as the PulseFX and the RightStart Piglet Processing System. By replacing traditional needles with high-pressure delivery technology, the firm addresses critical pain points in the livestock industry, including animal stress reduction, improved safety protocols, and enhanced operational efficiency. With a track record of delivering more needle-free injections than all market competitors combined, the company has established a dominant footprint among large-scale livestock producers in the United States and key international markets.
How much funding has Pulse NeedleFree Systems raised?
Pulse NeedleFree Systems has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pulse NeedleFree Systems
PPP
Public-Private Partnership
What's next for Pulse NeedleFree Systems?
With the infusion of $150K, Pulse NeedleFree Systems is well-positioned to accelerate its research and development initiatives. The company is expected to focus on scaling its manufacturing capabilities to meet the growing demand for compassionate and cost-effective animal health technology. Furthermore, the strategic capital will likely facilitate deeper market penetration into global livestock sectors, where the demand for precision agriculture tools is rising. As the firm transitions through this late-stage growth phase, the focus will remain on optimizing herd health outcomes and maintaining its competitive edge through continuous innovation in injection delivery systems.
See full Pulse NeedleFree Systems company page
